Skip to content

Startup & venture capital news

· Venture Capital

Proximal’s first fund bets on everything after drug discovery

The USD 27.5 million debut fund exceeded its target and will back AI infrastructure across the life-sciences value chain.

Proximal Ventures: Fund I
Proximal Ventures

Proximal Ventures has closed Fund I at USD 27.5 million, above its USD 25 million target. The San Francisco firm will invest at pre-seed and seed stage in AI-native tools for clinical development, manufacturing, commercialisation and other parts of the pharmaceutical value chain. It plans initial cheques of USD 500,000 to USD 1.5 million and has already backed seven companies. Founder Sahir Raoof started Proximal in 2026 after roles at SignalFire, Flatiron Health and Iterative Health.

Sources